New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 6, 2012
07:18 EDTCRISCuris announces U.S. patent issuance covering HSP90 inhibitor Debio 0932
Curis announced that the U.S. Patent and Trademark Office has issued a patent covering a genus of compounds that includes Debio 0932, an orally-administered Heat Shock Protein 90, or HSP90, inhibitor, which is being developed by Curis' licensee Debiopharm. The newly issued patent, U.S. Patent Number 8,324,240, is entitled "Fused Amino Pyridine as HSP90 Inhibitors."
News For CRIS From The Last 14 Days
Check below for free stories on CRIS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CRIS

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use